This exhibit includes portions from the previously published Results Announcement of Barclays PLC relating to the three months ended 31 March 2024, as amended in part to comply with the requirements of Regulation G and Item 10(e) of Regulation S-K promulgated by the US Securities and Exchange Commission (SEC), including the reconciliation of certain financial information to comparable measures prepared in accordance with International Financial Reporting Standards (IFRS). The purpose of this document is to provide such additional disclosure as required by Regulation G and Regulation S-K item 10(e), to delete certain information not in compliance with SEC regulations and to include reconciliations of certain non-IFRS figures to the most directly equivalent IFRS figures for the periods presented. This document does not update or otherwise supplement the information contained in the previously published Results Announcement. Any reference to a website in this document is made for informational purposes only, and information found at such websites is not incorporated by reference into this document.

An audit opinion has not been rendered in respect of this document.

The terms Barclays and Group refer to Barclays PLC together with its subsidiaries. Unless otherwise stated, the income statement analysis compares the three months ended 31 March 2024 to the corresponding three months of 2023 and balance sheet analysis as at 31 March 2024 with comparatives relating to 31 December 2023 and 31 March 2023. The abbreviations ‘£m’ and ‘£bn’ represent millions and thousands of millions of Pounds Sterling respectively; the abbreviations ‘$m’ and ‘$bn’ represent millions and thousands of millions of US Dollars respectively; and the abbreviations ‘€m’ and ‘€bn’ represent millions and thousands of millions of Euros respectively.

There are a number of key judgement areas, for example impairment calculations, which are based on models and which are subject to ongoing adjustment and modifications. Reported numbers reflect best estimates and judgements at the given point in time.

Relevant terms that are used in this document but are not defined under applicable regulatory guidance or International Financial Reporting Standards (IFRS) are explained in the results glossary, which can be accessed at home.barclays/investor-relations.

The information in this announcement, which was approved by the Board of Directors on 24 April 2024, does not comprise statutory accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 December 2023, which contain an unmodified audit report under Section 495 of the Companies Act 2006 (which does not make any statements under Section 498 of the Companies Act 2006) has been delivered to the Registrar of Companies in accordance with Section 441 of the Companies Act 2006.

Barclays is a frequent issuer in the debt capital markets and regularly meets with investors via formal roadshows and other ad hoc meetings. Consistent with its usual practice, Barclays expects that from time to time over the coming quarter it will meet with investors globally to discuss these results and other matters relating to the Group.

Barclays’ management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses’ performance between financial periods and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by Barclays’ management. However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well. Refer to the appendix on pages 42 to 46.

Key non-IFRS measures included in this document, and the most directly comparable IFRS measures, are:

– Average allocated equity represents the average shareholders’ equity that is allocated to the businesses. The comparable IFRS measure is average equity. A reconciliation is provided on pages 43 to 44;

– Average allocated tangible equity (for businesses) is calculated as the average of the previous month’s period end allocated tangible equity and the current month’s period end allocated tangible equity. The average allocated tangible equity for the period is the average of the monthly averages within that period. Period end allocated tangible equity is calculated as 13.5% (2023: 13.5%) of RWAs for each business, adjusted for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the Barclays Group uses for capital planning purposes. Head Office allocated tangible equity represents the difference between the Barclays Group’s tangible shareholders’ equity and the amounts allocated to businesses. The comparable IFRS measure is average equity. A reconciliation is provided on pages 43 to 44;

– Average tangible shareholders’ equity (for Barclays Group) is calculated as the average of the previous month’s period end tangible shareholders' equity and the current month’s period end tangible shareholders' equity. The average tangible shareholders’ equity for the period is the average of the monthly averages within that period. The comparable IFRS measure is average equity. A reconciliation is provided on pages 42 to 43;

–Group net interest income (NII) excluding Barclays Investment Bank (IB) and Head Office represent group NII excluding IB NII and Head Office NII. The comparable IFRS measure is Group NII. A reconciliation is provided on page 45;

– Group operating costs represents group operating expenses excluding UK regulatory levies and litigation and conduct charges. The comparable IFRS measure is total operating expenses. A reconciliation is provided on page 45;

– Group operating expenses excluding litigation and conduct represents Group operating expenses excluding litigation and conduct charges. The comparable IFRS measure is total operating expenses. A reconciliation is provided on page 45;

– Return on average allocated equity represents the return on shareholders’ equity that is allocated to the businesses. The comparable IFRS measure is return on equity. A reconciliation is provided on page 46;

– Return on average allocated tangible equity (for businesses) is calculated as annualised Group attributable profit, as a proportion of average shareholders’ tangible equity. The comparable IFRS measure is return on equity. A reconciliation is provided on pages 43 to 44;

– Return on average tangible shareholders’ equity (for Barclays Group) is calculated as the annualised profit after tax attributable to ordinary equity holders of the parent, as a proportion of average shareholders’ equity excluding non-controlling interests and other equity instruments adjusted for the deduction of intangible assets and goodwill. The comparable IFRS measure is return on equity. A reconciliation is provided on page 42;

–Return on tangible equity excluding inorganic activity represents return on tangible equity excluding the impact of inorganic activity; and

– Tangible net asset value per share is calculated by dividing shareholders’ equity, excluding non-controlling interests and other equity instruments, less goodwill and intangible assets, by the number of issued ordinary shares. The comparable IFRS measure is net asset value per share. A reconciliation is provided on page 45.

This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, and Section 27A of the US Securities Act of 1933, as amended, with respect to the Group. Barclays cautions readers that no forward-looking statement is a guarantee of future performance and that actual results or other financial condition or performance measures could differ materially from those contained in the forward-looking statements. Forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements sometimes use words such as ‘may’, ‘will’, ‘seek’, ‘continue’, ‘aim’, ‘anticipate’, ‘target’, ‘projected’, ‘expect’, ‘estimate’, ‘intend’, ‘plan’, ‘goal’, ‘believe’, ‘achieve’ or other words of similar meaning. Forward-looking statements can be made in writing but also may be made verbally by directors, officers and employees of the Group (including during management presentations) in connection with this document. Examples of forward-looking statements include, among others, statements or guidance regarding or relating to the Group’s future financial position, business strategy, income levels, costs, assets and liabilities, impairment charges, provisions, capital leverage and other regulatory ratios, capital distributions (including policy on dividends and share buybacks), return on tangible equity, projected levels of growth in banking and financial markets, industry trends, any commitments and targets (including environmental, social and governance (ESG) commitments and targets), plans and objectives for future operations, and other statements that are not historical or current facts. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. Forward-looking statements speak only as at the date on which they are made. Forward-looking statements may be affected by a number of factors, including, without limitation: changes in legislation, regulations, governmental and regulatory policies, expectations and actions, voluntary codes of practices and the interpretation thereof, changes in IFRS and other accounting standards, including practices with regard to the interpretation and application thereof and emerging and developing ESG reporting standards; the outcome of current and future legal proceedings and regulatory investigations; the Group’s ability along with governments and other stakeholders to measure, manage and mitigate the impacts of climate change effectively; environmental, social and geopolitical risks and incidents and similar events beyond the Group’s control; the impact of competition in the banking and financial services industry; capital, liquidity, leverage and other regulatory rules and requirements applicable to past, current and future periods; UK, US, Eurozone and global macroeconomic and business conditions, including inflation; volatility in credit and capital markets; market related risks such as changes in interest rates and foreign exchange rates reforms to benchmark interest rates and indices; higher or lower asset valuations; changes in credit ratings of any entity within the Group or any securities issued by it; changes in counterparty risk; changes in consumer behaviour; the direct and indirect consequences of the conflicts in Ukraine and the Middle East on European and global macroeconomic conditions, political stability and financial markets; political elections; developments in the UK’s relationship with the European Union (“EU”); the risk of cyberattacks, information or security breaches, technology failures or operational disruptions and any subsequent impact on the Group’s reputation, business or operations; the Group’s ability to access funding; and the success of acquisitions, disposals and other strategic transactions. A number of these factors are beyond the Group’s control. As a result, the Group’s actual financial position, results, financial and non-financial metrics or performance measures or its ability to meet commitments and targets may differ materially from the statements or guidance set forth in the Group’s forward-looking statements. In setting its targets and outlook for the period 2024-2026, Barclays has made certain assumptions about the macroeconomic environment, including, without limitation, inflation, interest and unemployment rates, the different markets and competitive conditions in which Barclays operates, and its ability to grow certain businesses and achieve costs savings and other structural actions. Additional risks and factors which may impact the Group’s future financial condition and performance are identified in Barclays PLC’s filings with the US Securities and Exchange Commission (“SEC”) (including, without limitation, Barclays PLC’s Annual Report on Form 20-F for the financial year ended 31 December 2023), which are available on the SEC’s website at www.sec.gov.

Subject to Barclays PLC's obligations under the applicable laws and regulations of any relevant jurisdiction (including, without limitation, the UK and the US) in relation to disclosure and ongoing information, we undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

In Q124 Barclays delivered a return on equity (RoE) of 10.6%, return on tangible equity (RoTE) of 12.3%, a net asset value (NAV) per share of 387p and a tangible net asset value (TNAV) per share of 335p. RoTE1 target of greater than 10% in 2024 remains unchanged

•Group cost: income ratio of 60%. Target of c.63% in 2024 remains unchanged

•Delivered £0.2bn of the c.£1bn 2024 gross cost efficiency savings

•Loan loss rate (LLR) of 51bps, within the expected through the cycle range of 50-60bps

•CET1 ratio of 13.5%, in the middle of the target range of 13-14%

•Announced acquisition of Tesco Bank's retail banking business2, expected to complete in Q424

•Announced sale of the performing Italian mortgage portfolio, expected to complete in Q224

•Group RoE was 10.6% (Q123: 12.8%), Group RoTE was 12.3% (Q123: 15.0%) with profit before tax of £2.3bn (Q123: £2.6bn)

•Group income of £7.0bn down 4% year-on-year, with Group net interest income (NII) of £3.1bn and Group NII excluding Barclays Investment Bank (IB) and Head Office of £2.7bn, of which Barclays UK NII of £1.5bn

–Barclays UK income decreased 7%, as higher structural hedge income was more than offset by adverse product dynamics in deposits and mortgages, in addition to the transfer of Wealth Management & Investments (WM&I) to Barclays Private Bank and Wealth Management (PBWM)3

–Barclays UK Corporate Bank (UKCB) income decreased 6%, reflecting lower liquidity pool income whilst maintaining stable average deposits

–PBWM income increased 20%, reflecting the transfer of WM&I from Barclays UK, partially offset by lower NII due to adverse deposit dynamics

–IB income decreased 7%. Within Global Markets, strong performance in Equities was more than offset by lower FICC income. In Investment Banking, increased fee income in Debt and Equity capital markets were more than offset by lower fee income in Advisory and lower income in Transaction banking

–Barclays US Consumer Bank (USCB) income increased 4%, reflecting higher cards balances

•Group total operating expenses were £4.2bn, up 2% year-on-year, including the £120m impact of the Bank of England (BoE) levy scheme

–Group operating costs decreased 3%, reflecting £0.2bn of efficiency savings, more than offsetting the impact of inflation, investment spend and business growth

•Credit impairment charges were £0.5bn (Q123: £0.5bn) with an LLR of 51bps (Q123: 52bps)

•CET1 ratio of 13.5% (December 2023: 13.8%), with Risk Weighted Assets (RWAs) of £349.6bn (December 2023: £342.7bn). NAV per share of 387p (December 2023: 382p) and TNAV per share of 335p (December 2023: 331p)

1Management does not assess forward-looking “return on equity” (target RoE) as a performance indicator of the business, and therefore a reconciliation of the forward-looking non-IFRS measure “return on tangible equity” (target RoTE) to an equivalent IFRS measure is not available without unreasonable efforts.

2See Other matters on page 8 for further details on the acquisition of Tesco Bank's retail banking business.

3WM&I was transferred out of Barclays UK in Q223.

•Returns: targeting RoTE1 of greater than 10% and c.10.5% excluding inorganic activity

•Income: targeting Barclays Group NII excluding IB and Head Office2 of c.£10.7bn, of which Barclays UK NII of c.£6.1bn3

•Costs: targeting Group cost: income ratio of c.63%, which includes c.£1bn of gross efficiency savings in 2024

•Impairment: expect an LLR of 50-60bps through the cycle

•Capital: expect to operate within the CET1 ratio target range of 13-14%

•Returns: targeting a greater than 12% RoTE1

•Capital returns: plan to return at least £10bn of capital to shareholders between 2024 and 2026, through dividends and share buybacks, with a continued preference for buybacks. Plan to keep total dividend stable at 2023 level in absolute terms, with progressive dividend per share growth driven through share count reduction as a result of increased share buybacks. Dividends will continue to be paid semi-annually. This multi year plan is subject to supervisory and Board approval, anticipated financial performance and our published CET1 ratio target range of 13-14%

•Income: targeting Group total income of c.£30bn

•Costs: targeting total Group operating expenses of c.£17.0bn and a Group cost: income ratio of high 50s in percentage terms. This includes total gross efficiency savings of c.£2bn by 2026

•Impairment: expect an LLR of 50-60bps through the cycle

•Capital: expect to operate within the CET1 ratio target range of 13-14%

–Targeting IB RWAs of c.50% of Group RWAs in 2026

–Impact of regulatory change on RWAs in line with prior guidance, expected to be at lower end of 5–10% of Group RWAs. This includes c.£16bn RWAs expected in H224 due to USCB moving to Internal Ratings-Based (IRB) models

•Barclays segmental reporting now reflects five operating divisions, in addition to Head Office:

–Barclays UK

–Barclays UK Corporate Bank

–Barclays Private Bank and Wealth Management

–Barclays Investment Bank

–Barclays US Consumer Bank

1Management does not assess forward-looking “return on equity” (target RoE) as a performance indicator of the business, and therefore reconciliations of the forward-looking non-IFRS measures “return on tangible equity” (target RoTE) and “return on tangible equity excluding inorganic activity” to an equivalent IFRS measure are not available without unreasonable efforts.

2Management does not assess forward-looking “Group NII excluding IB and Head Office” (target) as a performance indicator of the business, and therefore a reconciliation of the forward-looking non-IFRS measure “Group NII excluding IB and Head Office” (target) to an equivalent IFRS measure is not available without unreasonable efforts.

3This excludes the impact of the acquisition of Tesco Bank's retail banking business, which is expected to generate annualised NII of c.£400m in the first year post-completion. See Other Matters on page 8 for further details of the acquisition.

Barclays Group results
for the three months ended															31.03.24			31.03.23
															£m			£m			% Change
Barclays UK															1,826			1,961			(7)
Barclays UK Corporate Bank															434			463			(6)
Barclays Private Bank and Wealth Management															312			259			20
Barclays Investment Bank															3,328			3,569			(7)
Barclays US Consumer Bank															859			826			4
Head Office															194			159			22
Total income															6,953			7,237			(4)
Operating costs															(3,998)			(4,111)			3
UK regulatory levies1															(120)			—			#DIV/0!
Litigation and conduct															(57)			1
Total operating expenses															(4,175)			(4,110)			(2)
Other net income/(expenses)															12			(5)
Profit before impairment															2,790			3,122			(11)
Credit impairment charges															(513)			(524)			2
Profit before tax															2,277			2,598			(12)
Tax charge															(465)			(561)			17
Profit after tax															1,812			2,037			(11)
Non-controlling interests															(3)			(8)			63
Other equity instrument holders															(259)			(246)			(5)
Attributable profit															1,550			1,783			(13)
Performance measures
Return on average shareholders' equity															10.6%			12.8%
Return on average tangible shareholders' equity															12.3%			15.0%
Average shareholders' equity (£bn)															58.3			55.9
Average tangible shareholders' equity (£bn)															50.5			47.6
Cost: income ratio															60%			57%
Loan loss rate (bps)															51			52
Basic earnings per ordinary share															10.3p			11.3p
Basic weighted average number of shares (m)															14,983			15,770			(5)
Period end number of shares (m)															15,091			15,701			(4)

			As at 31.03.24			As at 31.12.23			As at 31.03.23
Balance sheet and capital management2			£bn			£bn			£bn
Loans and advances at amortised cost			397.9			399.5			403.5
Loans and advances at amortised cost impairment coverage ratio			1.4%			1.4%			1.4%
Total assets			1,577.1			1,477.5			1,539.1
Deposits at amortised cost			552.3			538.8			555.7
Net asset value per share			387p			382p			356p
Tangible net asset value per share			335p			331p			301p
Common equity tier 1 ratio			13.5%			13.8%			13.6%
Common equity tier 1 capital			47.1			47.3			46.0
Risk weighted assets			349.6			342.7			338.4
UK leverage ratio			4.9%			5.2%			5.1%
UK leverage exposure			1,226.5			1,168.3			1,168.9
Funding and liquidity
Group liquidity pool (£bn)			323.5			298.1			333.0
Liquidity coverage ratio3			163%			161%			157%
Net stable funding ratio4			136%			138%			139%
Loan: deposit ratio			72%			74%			73%

1Comprises the impact of the BoE levy scheme and the UK bank levy.

2Refer to pages 34 to 38 for further information on how capital, RWAs and leverage are calculated.

3The liquidity coverage ratio (LCR) is now shown on an average basis, based on the average of the last 12 spot month end ratios. Prior period LCR comparatives have been updated for consistency.

4Represents average of the last four spot quarter end positions.

•Barclays delivered a profit before tax of £2,277m (Q123: £2,598m), RoE of 10.6% (Q123: 12.8%), RoTE of 12.3% (Q123: 15.0%) and earnings per share (EPS) of 10.3p (Q123: 11.3p)

•Group income decreased 4% to £6,953m as higher structural hedge income, strong performance in Equities and balance growth in USCB were more than offset by lower FICC income in IB, lower inflation linked income as well as adverse product dynamics in Barclays UK deposits and mortgages

•Group total operating expenses increased to £4,175m (Q123: £4,110m) including the £120m impact of the BoE levy scheme

–Group operating costs decreased 3% to £3,998m, reflecting efficiency savings, partially offset by the impact of inflation, investment spend and business growth

•Credit impairment charges were £513m (Q123: £524m), driven by the anticipated higher delinquencies in USCB, which led to a higher coverage ratio of 11.0% in that portfolio. Total coverage ratio remains stable at 1.4% (December 2023: 1.4%)

•The effective tax rate (ETR) was 20.4% (Q123: 21.6%)

•Attributable profit was £1,550m (Q123: £1,783m)

•Total assets increased to £1,577.1bn (December 2023: £1,477.5bn) driven by an increase in trading securities and secured lending in IB, and an increase in the liquidity pool due to increased deposits

•NAV per share increased to 387p (December 2023: 382p) and TNAV per share increased to 335p (December 2023: 331p) as EPS of 10.3p was partially offset by negative cash flow hedge reserve movements of 2p, and net negative other reserve movements

•The CET1 ratio decreased to 13.5% (December 2023: 13.8%) as RWAs increased by £6.9bn to £349.6bn and CET1 capital decreased by £0.2bn to £47.1bn:

–c.40bps increase from attributable profit generated in the quarter

–c.40bps decrease driven by shareholder distributions including the £1.0bn share buyback announced with FY23 results and an accrual towards the FY24 dividend

–c.30bps decrease as a result of a £6.9bn increase in RWAs primarily driven by expected seasonal activity in the Investment Bank and regulatory model changes in Barclays UK which are expected to be partially offset for the full year

•The UK leverage ratio decreased to 4.9% (December 2023: 5.2%) primarily due to a £58.2bn increase in leverage exposure to £1,226.5bn, largely driven by an increase in trading securities and secured lending in Global Markets

•The liquidity metrics remain well above regulatory requirements, underpinned by well-diversified sources of funding, a stable global deposit franchise and a highly liquid balance sheet

•The liquidity pool was £323.5bn (December 2023: £298.1bn). The increase in the liquidity pool was driven by the expected increase in short term bank deposits after a drop at the year-end and a strong deposit growth in International Corporate Bank which is partially offset by a slight seasonal decline in Barclays UK deposits

•The average1 Liquidity Coverage Ratio (LCR) increased to 163% (December 2023: 161%), equivalent to a surplus of £117.8bn (December 2023: £117.7bn)

•Total deposits increased by £13.5bn to £552.3bn (December 2023: £538.8bn)

•The average2 Net Stable Funding Ratio (NSFR) was 136% (December 2023: 138%), which represents a £160.4bn (December 2023: £167.1bn) surplus above the 100% regulatory requirement

•Wholesale funding outstanding, excluding repurchase agreements, was £190.6bn (December 2023: £176.8bn)

•The Group issued £5.4bn equivalent of minimum requirement for own funds and eligible liabilities (MREL) instruments from Barclays PLC (the Parent company) in Q124. The Group has a strong MREL position with a ratio of 33.4%, which is in excess of the regulatory requirement of 30.1% plus a confidential, institution specific, Prudential Regulation Authority (PRA) buffer

1Represents average of the last 12 spot month end ratios.

2Represents average of the last four spot quarter end ratios.

•Acquisition of Tesco Bank's retail banking business: on 9 February 2024, Barclays entered into an agreement with Tesco Personal Finance plc (operating using the trading name “Tesco Bank”) to acquire its retail banking business. The acquisition is expected to reduce Barclays' CET1 ratio by c.30bps on completion, which is expected to occur in Q424, subject to court sanction and regulatory approvals

•FCA motor finance review: in January 2024, the UK Financial Conduct Authority (FCA) announced that it was appointing a skilled person to undertake a review of the historical use of discretionary commission arrangements and sales in the motor finance market across several firms. The FCA plans to set out next steps on this matter by the end of September 2024. Clydesdale Financial Services Limited (CFS), a member of the Group, ceased operating in the motor finance market in late 2019 but is co-operating fully with the FCA’s skilled person review, the outcome of which is unknown, including any potential financial impact. The FCA intervention followed two final decisions by the UK Financial Ombudsman Service (FOS), including one upholding a complaint against CFS in relation to commission arrangements and disclosure in the sale of motor finance products and a number of complaints and court claims, including some against CFS. We have commenced a judicial review challenge to the FOS in the High Court in relation to this decision

•BoE levy scheme: following parliamentary approval, the new levy process commenced in Q124 replacing the Cash Ratio Deposit scheme as a means of funding the Bank of England's monetary policy and financial stability operations. This change in scheme moves the charge from negative income recognised over the course of the year to an annual operating expense at the start of the levy year (running from 1 March to 28 February). Barclays' estimated contribution for the 2024/2025 financial year is £120m, reported in the UK regulatory levies account line, reducing Q124 Group RoE by c.0.6% and Group RoTE by c.0.7%. This will be partially offset by increased income of c.£75m through lower funding costs during 2024, with an expected overall net full year Group RoE impact of c.0.1% and Group RoTE impact of c.0.1%. The final charge is expected to be confirmed during Q324

•Disposal of Italian retail mortgages: on 24 April 2024, Barclays announced a transaction under which Barclays Bank Ireland PLC intends to dispose of its performing Italian retail mortgage book currently held in Head Office. The sale is expected to complete in Q224. It is expected to generate a pre-tax loss of c.£225m for the year to 31 December 2024 and reduce RWAs by c.£0.8bn at completion. The transaction is expected to be broadly neutral to Barclays’ CET1 ratio

–In addition, Barclays is in discussion with respect to the disposals of the remaining non-performing and Swiss-Franc linked Italian retail mortgage portfolios. Should such sales occur, they are together expected to generate a small pre-tax loss on sale, but also be broadly neutral to Barclays’ CET1 ratio

•Sale of German consumer finance business: Barclays is currently engaged in a process to sell its German consumer finance business (comprising credit cards, unsecured personal loans and deposits), held in Head Office, as part of our ambition to simplify Barclays and support our focus on growing our key businesses. The sale is expected to complete in H224, and be accretive to Barclays' CET1 ratio

Barclays UK delivered a RoE of 13.4% and a RoTE of 18.5% supported by resilient returns and the continued investment in our transformation into a simpler, better and more balanced retail bank.

•Profit before tax decreased 6% to £705m with a RoE of 13.4% (Q123: 14.8%) and a RoTE of 18.5% (Q123: 20.0%)

•Total income decreased 7% to £1,826m. NII decreased 4% to £1,549m, as continued structural hedge momentum was more than offset by mortgage margin pressure and adverse deposit dynamics reflecting wider market trends. Net fee, commission and other income decreased 19% to £277m primarily from the impact of the transfer of WM&I to PBWM

•Total operating expenses decreased 3% to £1,063m driven by the transfer of WM&I to PBWM partially offset by the impact of inflation and the impact of the BoE levy scheme. Ongoing efficiency savings continue to be reinvested, including in our transformation programme to support sustainable improvement to the cost: income ratio

•Credit impairment charges were £58m (Q123: £113m), consistent with low delinquencies in UK cards, high quality mortgage lending portfolio and the improved macroeconomic outlook. UK cards 30 and 90 day arrears remained low at 0.9% (Q123: 0.9%) and 0.2% (Q123: 0.2%) respectively. The UK cards total coverage ratio was 6.5% (December 2023: 6.8%)

•Loans and advances to customers at amortised cost decreased by 1% to £200.8bn (December 2023: £202.8bn), reflecting subdued mortgage lending amid lower market demand and continued repayment of government scheme lending in Business Banking

•Customer deposits at amortised cost decreased 2% to £237.2bn (December 2023: £241.1bn), driven by reduced current account balances, reflecting broader market trends. The loan: deposit ratio remained stable at 92% (December 2023: 92%)

•RWAs increased to £76.5bn (December 2023: £73.5bn) driven by regulatory model changes which are expected to be partially offset for the full year

UKCB delivered a RoE of 15.2% and a RoTE of 15.2%, with stable average deposits supporting strong returns despite lower liquidity pool income, the impact of the BoE levy scheme and continued investment to support future growth ambitions.

•Profit before tax decreased 27% to £168m with a RoE of 15.2% (Q123: 21.7%) and RoTE of 15.2% (Q123: 21.7%)

•Total income decreased 6% to £434m. NII decreased 11% to £277m reflecting lower liquidity pool income. Net fee, commission, trading and other income was stable at £157m (Q123: £153m)

•Total operating expenses increased 20% to £251m, reflecting the impact of the BoE levy scheme and higher investment spend to support future growth ambitions

•Credit impairment charges were £15m (Q123: £24m), driven by resilient underlying credit performance and the improved macroeconomic outlook

•RWAs were broadly stable at £21.4bn (December 2023: £20.9bn)

PBWM delivered a RoE of 26.3% and a RoTE of 28.7%, supported by growth in client balances of c.£48bn, which is predominantly invested assets2 as a result of WM&I transfer and underlying growth.

•Profit before tax decreased 15% to £95m with a RoE of 26.3% (Q123: 31.6%) and a RoTE of 28.7% (Q123: 34.5%)

•Total income increased 20% to £312m. NII decreased 3% to £175m mainly due to adverse deposit dynamics reflecting wider market trends. Net fee, commission and other income increased 76% to £137m reflecting the transfer of WM&I from Barclays UK and client balance growth

•Total operating expenses increased 51% to £217m, reflecting the transfer of WM&I from Barclays UK and higher investment spend to support growth

•RWAs were stable at £7.2bn (December 2023: £7.2bn)

1Client assets and liabilities refers to customer deposits, lending and invested assets, including c.£28bn WM&I invested assets transferred from Barclays UK in May 2023.

2Invested assets represent assets under management and supervision.

Barclays Investment Bank									Three months ended
															31.03.24			31.03.23
Income statement information															£m			£m			% Change
Net interest income															197			159			24
Net trading income															1,982			2,435			(19)
Net fee, commission and other income															1,149			975			18
Total income															3,328			3,569			(7)
Operating costs															(1,957)			(2,032)			4
UK regulatory levies															(33)			—			#DIV/0!
Litigation and conduct															(9)			2
Total operating expenses															(1,999)			(2,030)			2
Other net expenses															—			(1)
Profit before impairment															1,329			1,538			(14)
Credit impairment releases/(charges)															10			(25)
Profit before tax															1,339			1,513			(12)
Attributable profit															899			1,048			(14)
Performance measures
Return on average allocated equity															12.0%			14.4%
Return on average allocated tangible equity															12.0%			14.4%
Average allocated equity (£bn)															30.0			29.1
Average allocated tangible equity (£bn)															30.0			29.1
Cost: income ratio															60%			57%
Loan loss rate (bps)															(4)			10
															As at 31.03.24			As at 31.12.23			As at 31.03.23
Balance sheet information															£bn			£bn			£bn
Loans and advances to customers at amortised cost															64.6			62.7			63.1
Loans and advances to banks at amortised cost															7.6			7.3			9.1
Debt securities at amortised cost															40.4			38.9			30.7
Loans and advances at amortised cost															112.6			108.9			102.9
Trading portfolio assets															195.3			174.5			137.6
Derivative financial instrument assets															248.9			255.1			256.5
Financial assets at fair value through the income statement															225.1			202.5			243.8
Cash collateral and settlement balances															129.8			102.3			124.3
Other assets															200.4			175.8			198.8
Total assets															1,112.1			1,019.1			1,063.9
Deposits at amortised cost															151.1			132.7			137.3
Derivative financial instrument liabilities															241.5			249.7			246.7
Risk weighted assets															200.4			197.3			198.0

															Three months ended
															31.03.24			31.03.23
Analysis of total income															£m			£m			% Change
FICC															1,404			1,788			(21)
Equities															883			704			25
Global Markets															2,287			2,492			(8)
Advisory															148			212			(30)
Equity capital markets															68			50			36
Debt capital markets															401			341			18
Fees															617			603			2
Corporate lending															42			33			27
Transaction banking															382			441			(13)
International Corporate Bank															424			474			(11)
Investment Banking															1,041			1,077			(3)
Total income															3,328			3,569			(7)

IB delivered a RoE of 12.0% and a RoTE of 12.0% reflecting the benefit of diversified income streams with an increase in Equities and Investment Banking fee income, offset by a decrease in FICC income from lower client activity, lower costs and a net credit impairment release following improvements in macro economic outlook.

•IB RoE was 12.0% (Q123: 14.4%) and RoTE was 12.0% (Q123: 14.4%) with a profit before tax of £1,339m (Q123: £1,513m)

•Total income decreased 7% to £3,328m

•Global Markets income decreased 8% to £2,287m as a strong performance in Equities was more than offset by lower income in FICC. Equities income increased 25% to £883m, driven by growth in Derivatives, Cash and Prime financing balances, additionally supported by a £125m fair value gain on Visa B shares. FICC income decreased 21% to £1,404m, reflecting lower client activity in Macro and the non-repeat of inflation benefit from prior year, partially offset by strong performance in securitised products

•Investment Banking income decreased 3% to £1,041m

◦Investment Banking fee income increased 2% to £617m driven by Equity and Debt capital markets. Equity and Debt capital markets fees increased 36% and 18% respectively, reflecting improved fee pool and market share1 with Advisory income decreasing 30% against a strong prior year comparator2

◦International Corporate Bank income decreased 11% to £424m, mainly driven by Transaction banking which decreased 13% to £382m due to margin compression as customers migrate to higher interest returning products whilst total deposit balances remained stable and lower liquidity pool income. Corporate lending income increased to £42m (Q123: £33m) mainly from lower costs of hedging

•Total operating expenses decreased 2% to £1,999m reflecting efficiency savings, partially offset by the impact of the BoE levy scheme and the impact of inflation

•Credit impairment net release of £10m (Q123: £25m charge), driven by the improved macroeconomic outlook and the benefit of credit protection with limited single name charges in the period

•RWAs increased to £200.4bn (December 2023: £197.3bn) driven by expected seasonal activity across Global Markets and Investment Banking

1Data source: Dealogic for the period covering 1 January to 31 March 2024.

2On a comparable basis, period covering 2014-Q124.

USCB delivered a RoE of 4.8% and a RoTE of 5.3%, with growth in cards balances, and sold c.£0.9bn ($1.1bn) of the outstanding credit card receivables to Blackstone, which reduced our capital requirements.

•Profit before tax was £59m (Q123: £78m) with a RoE of 4.8% (Q123: 6.0%) and RoTE of 5.3% (Q123: 7.5%)

•Total income increased 4% to £859m. NII increased of 9% to £688m reflecting higher cards balances. Net fee, commission and other income decreased 11% to £171m as increased profit drove a higher partner profit share

•Total operating expenses decreased 9% to £390m, driven by efficiency savings and lower marketing costs

•Credit impairment charges increased to £410m (Q123: £321m), driven by the anticipated higher delinquencies, which led to higher coverage ratios. 30 and 90 day arrears were 3.1% (Q123: 2.3%) and 1.7% (Q123: 1.2%) respectively. The US cards total coverage ratio was 11.0% (December 2023: 10.2%)

•RWAs decreased to £23.9bn (December 2023: £24.8bn), reflecting the Blackstone sale and the seasonal decline in receivables

•Loss before tax was £89m (Q123: £89m)

•Total income increased to £194m (Q123: £159m) driven by a gain on disposal of a legacy investment and increased German cards income, partially offset by lower Payments income, hedge accounting and treasury items

•Total operating expenses increased to £255m (Q123: £205m) driven by higher litigation and conduct charges

•Credit impairment charges were £40m (Q123: £38m), reflecting stable credit performance

•RWAs increased to £20.2bn (December 2023: £19.0bn)

1Refer to pages 34 to 38 for further information on how capital, RWAs and leverage are calculated.

2The Liquidity Coverage Ratio is based on the average of the last 12 spot month end ratios. Prior period LCR comparatives have been updated for consistency.

3Represents average of the last four spot quarter end positions.